245 related articles for article (PubMed ID: 19192435)
1. A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.
Rothbaum BO; Davidson JR; Stein DJ; Pedersen R; Musgnung J; Tian XW; Ahmed S; Baldwin DS
J Clin Psychiatry; 2008 Oct; 69(10):1529-39. PubMed ID: 19192435
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
[TBL] [Abstract][Full Text] [Related]
3. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
Davidson J; Baldwin D; Stein DJ; Kuper E; Benattia I; Ahmed S; Pedersen R; Musgnung J
Arch Gen Psychiatry; 2006 Oct; 63(10):1158-65. PubMed ID: 17015818
[TBL] [Abstract][Full Text] [Related]
4. Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.
Stein DJ; Pedersen R; Rothbaum BO; Baldwin DS; Ahmed S; Musgnung J; Davidson J
Int J Neuropsychopharmacol; 2009 Feb; 12(1):23-31. PubMed ID: 18544181
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
6. Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo.
Davidson J; Stein DJ; Rothbaum BO; Pedersen R; Szumski A; Baldwin DS
J Psychopharmacol; 2012 Jun; 26(6):778-83. PubMed ID: 21926426
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
[TBL] [Abstract][Full Text] [Related]
8. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
Davidson J; Baldwin DS; Stein DJ; Pedersen R; Ahmed S; Musgnung J; Benattia I; Rothbaum BO
Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
Liebowitz MR; Asnis G; Mangano R; Tzanis E
J Clin Psychiatry; 2009 Apr; 70(4):550-61. PubMed ID: 19358784
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine versus placebo in posttraumatic stress disorder.
Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR; Gelenberg AJ; Munjack D
Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
Kroenke K; Messina N; Benattia I; Graepel J; Musgnung J
J Clin Psychiatry; 2006 Jan; 67(1):72-80. PubMed ID: 16426091
[TBL] [Abstract][Full Text] [Related]
15. Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.
Ferguson JM; Khan A; Mangano R; Entsuah R; Tzanis E
J Clin Psychiatry; 2007 Jan; 68(1):58-68. PubMed ID: 17284131
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
17. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
[TBL] [Abstract][Full Text] [Related]
18. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
Mallick R; Chen J; Entsuah AR; Schatzberg AF
J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial.
Fann JR; Bombardier CH; Richards JS; Wilson CS; Heinemann AW; Warren AM; Brooks L; McCullumsmith CB; Temkin NR; Warms C; Tate DG;
JAMA Psychiatry; 2015 Mar; 72(3):247-58. PubMed ID: 25607727
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Silverstone PH; Salinas E
J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
